π¦ Update on β5 BY 25β: Progress, Challenges and Next Steps in Countering AMR
GARDP will host a live webinar reflecting ...
π¦ Update on β5 BY 25β: Progress, Challenges and Next Steps in Countering AMR
GARDP will host a live webinar reflecting on the β5 BY 25β initiative, launched in 2019 with the ambitious goal of developing five new antibiotic treatments between 2020 and 2025. The session will highlight key achievements, lessons learned, and remaining challenges, while outlining how GARDP is building on this progress to advance sustainable, public healthβdriven antibiotic R&D and access ππ.
The webinar will feature insights from leading experts Anand Anandkumar (Bugworks), Manica Balasegaram (GARDP), Glenda Gray (SAMRC), and David Paterson (ADVANCE-ID), and will be moderated by Herman Goossens (University of Antwerp).
π 15 January 2026 | 12:00β13:00 CET π¬ Live broadcast with interactive Q&A
π¦ Update on β5 BY 25β: Progress, Challenges and Next Steps in Countering AMR
GARDP will host a live webinar reflecting on the β5 BY 25β initiative, launched in 2019 with the ambitious goal of developing five new antibiotic treatments between 2020 and 2025. The session will highlight key achievem...
π¦ Update on β5 BY 25β: Progress, Challenges and Next Steps in Countering AMR
GARDP will host a live webinar reflecting on the β5 BY 25β initiative, launched in 2019 with the ambitious goal of developing five new antibiotic treatments between 2020 and 2025. The session will highlight key achievements, lessons learned, and remaining challenges, while outlining how GARDP is building on this progress to advance sustainable, public healthβdriven antibiotic R&D and access ππ.
The webinar will feature insights from leading experts Anand Anandkumar (Bugworks), Manica Balasegaram (GARDP), Glenda Gray (SAMRC), and David Paterson (ADVANCE-ID), and will be moderated by Herman Goossens (University of Antwerp).
π 15 January 2026 | 12:00β13:00 CET π¬ Live broadcast with interactive Q&A